Pharma Exec Martin Shkreli Pleads Not Guilty to Securities Fraud
A pharmaceutical executive who came under fire for jacking up the price of a lifesaving malaria medication has pleaded not guilty to new charges in his securities fraud case. Martin Shkreli appeared Monday in federal court in New York City. He declined to speak to reporters as he left the courthouse. A revised indictment filed last week alleged Shkreli and…
